Macrolide and Ketolide Resistance with Streptococcus pneumoniae
Author:
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 90 (6) , 1109-1124
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Streptococcus pneumoniae Isolates Resistant to TelithromycinAntimicrobial Agents and Chemotherapy, 2006
- Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Emergence of a Streptococcus pneumoniae Clinical Isolate Highly Resistant to Telithromycin and FluoroquinolonesJournal of Clinical Microbiology, 2005
- Molecular Characterization of the First Telithromycin-Resistant Streptococcus pneumoniae Isolate in GermanyAntimicrobial Agents and Chemotherapy, 2005
- Predominance of 23S rRNA Mutants among Non-Erm, Non-Mef Macrolide-Resistant Clinical Isolates of Streptococcus pneumoniae Collected in the United States in 1999-2000Antimicrobial Agents and Chemotherapy, 2005
- Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and ChemotherapyVaccine, 2003
- Changes in Antibiotic‐Prescribing Practices and Carriage of Penicillin‐ResistantStreptococcus pneumoniae:A Controlled Intervention Trial in Rural AlaskaClinical Infectious Diseases, 2002
- ReplyClinical Infectious Diseases, 2002
- Randomized, Placebo‐Controlled Clinical Trial of Oral Azithromycin Prophylaxis against Respiratory Infections in a High‐Risk, Young Adult PopulationClinical Infectious Diseases, 2001
- TelithromycinDrugs, 2001